Beta-Hydroxybutyrate Dehydrogenase (H-010)

EKF Diagnostics Holdings plc

Penarth Cardiff, United Kingdom

Enabling informed decisions in point-of-care testing and life sciences applications. EKF is a leading global diagnostics and biotech company focused on creating, producing, and distributing innovative medical technologies and patient-centric solutions. We are committed to delivering high-quality, reliable, cost-effective tools that enable early detection, accurate diagnosis, therapeutic development, and effective condition monitoring. Our products are designed to be cost-effective, providing accessible solutions to healthcare providers in diverse clinical settings, including hospitals, clinics, and laboratories. EKF plays a critical role in the healthcare industry by offering high-quality, value-based diagnostic products. Our point-of-care testing (POCT) devices allow healthcare professionals to perform rapid tests at the patient s side, reducing the need for extensive lab testing and delivering quicker results. In addition to POCT, EKF is at the forefront of the life sciences sector, providing advanced tools that contribute to biotech research and development worldwide.